Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

US Patent 11279934 · Granted Mar 22, 2022

Estimated economic value: $196,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNA interference in ocular indications2023
Neutral nanotransporters2022
Reduced size self-delivering RNAI compounds2021
Reduced size self-delivering nucleic acid compounds targeting long non-coding RN2021
Reduced size self-delivering nucleic acid compounds targeting long non-coding RN2021
Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)2021
Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)2021
Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)2021
RNA interference in dermal and fibrotic indications2021
RNA interference in dermal and fibrotic indications2021
Reduced size self-delivering RNAI compounds2020
RNA interference in skin indications2020